drugset
drugset / Trial / NCT06857695

A Study to Assess the Mass Balance and ADME of [14C]AZD5004 and the Absolute Bioavailability of AZD5004

NCT06857695 ↗

Phase 1 Completed 8 enrolled AstraZeneca Quotient Sciences · collab
NaSingle-groupOpen-labelTreatment

Summary

This study in healthy volunteers aims to answer these questions: * Does the test medicine cause any important side effects? * What are the blood levels of the test medicine and how quickly does the body get rid of it? * How much of the test medicine taken by mouth gets into the bloodstream? * How does the body break down and get rid of the test medicine? This study will take place at one site in Nottingham, United Kingdom, and plans to enrol 8 healthy men aged 30-65 years, who will be involved in both parts of the study.

Timeline

Start
2025-03-06
Primary completion
2025-05-05
Completion
2025-05-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD5004 Unknown — Oral

Indications

No indication recorded.